Authors
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
A Roadmap for Implementing RBM and Quality ManagementThe importance of applying change management techniques throughout the preparation, planning, and execution of RBM and RBQM approaches.
Latest:
Innovative Clinical Outcome Assessment (COA) Solutions for Obesity Trials: Measuring MattersWebinar Date/Time: Tuesday, May 6th, 2025 at 11am EDT|8am PDT|4pm BST|5pm CEST
Latest:
Machine Learning within the Clinical Trial ProcessMachine learning technology is finding it’s way into today’s marketplace, specifically within business processes, by driving insurmountable value for corporations within the life science industry, writes Adam Ross Miller.
Latest:
US Clinical Investigator ExperienceThis data analysis takes a look at how much experience US clinical investigators have.
Latest:
Three Steps to A Successful Combination Product TrialSponsors can streamline the design and execution of their clinical trials by following this three-step approach.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
Estimands and Implications for Sponsors as ICH E9 (R1) Addendum ProgressesSponsors should be aware of the significant implications the Addendum is likely to have on clinical trial planning, conduct, statistical analysis, and interpretation.
Latest:
Why We Should Talk to Patients Who Drop Out of Clinical TrialsSandy Chase focuses on the voice of the patient and their experience after not completing a clinical trial.
Latest:
Improving the Traceability of the Clinical Trial Supply ChainOutlining the benefits of using blockchain technology across the supply chain to more securely record and distribute data to sites.
Latest:
Improving the Traceability of the Clinical Trial Supply ChainOutlining the benefits of using blockchain technology across the supply chain to more securely record and distribute data to sites.
Latest:
CDISC Glossary of Clinical Research TerminologyReference tool is a Rosetta Stone for clinical research. A look at the updates and enhancements in latest version.
Latest:
Demystifying Submissions of eCOA Documentation for Ethics Review: Are We Making Submissions More Difficult than Necessary?Examining how to optimizing the time and effort of Ethics Committees to efficiently and effectively fulfill their human subjects protection remit.
Latest:
CDISC Glossary of Clinical Research TerminologyReference tool is a Rosetta Stone for clinical research. A look at the updates and enhancements in latest version.
Latest:
Positive Changes for Clinical Trials in UkraineThe Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.
Latest:
Positive Changes for Clinical Trials in UkraineThe Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.
Latest:
Dermatology Biologics: Overcoming Challenges to Fulfill Therapeutic PotentialTo vie for success in the market for dermatologic therapies, companies developing biologics must navigate a series of significant challenges, including patient compliance and safety.
Latest:
Solving the Data Riddle to Yield Hope for Orphan DiseaseThis article will explore the issues of a lack of data standards; focusing on an industry hackathon that analyzed data sets relating to rare diseases.
Latest:
Metabolomics: Improving the Route from Early Drug Discovery through Clinical DevelopmentMetabolomics can make a positive impact from early drug discovery through clinical development and beyond.
Latest:
Sponsors Ask: Is Our Trial Plan Realistic? Toward a Data-Driven Feasibility AssessmentToday, a data-driven approach to feasibility assessment can help ensure that a sponsor’s clinical research plan is designed to enroll the right patients, rely on the right investigators, and take place in the right countries for success.
Latest:
Optimizing Technology Implementation to Improve Diversity in Clinical ResearchThree key considerations for deploying technology to help increase diversity in trials.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
